EVs isolated from plasma of NSCLC patients can be used for EGFR genotyping through sequential liquid biopsies during treatment for the detection drug-resistance mutations, like the pT790M, demonstrating improved concordance with testing of tumor tissue compared to a conventional liquid biopsy of ctDNA [121]. Here, EGFR is linked to non-small cell lung carcinoma.